Global Natural Killer Cell Therapies Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Natural Killer Cell Therapies is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Natural Killer Cell Therapies market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Natural Killer Cell Therapies industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Natural Killer Cell Therapies Market Segmentations:

    By Players:

    • Innate

    • Nkarta Therapeutics

    • Fate Therapeutics

    • Fortress Biotech

    • Chipscreen Biosciences

    • Glycostem

    • Nektar Therapeutics

    • NantWorks

    • Kiadis Pharma

    • Dragonfly Therapeutics

    • Affimed

    By Types:

    • NK Cell Therapies

    • NK Cell Directed Antibodies

    By End-User:

    • Cancer

    • Gastrointestinal Diseases

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Natural Killer Cell Therapies Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Therapies from 2014 to 2026

      • 1.3.2 Global Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Directed Antibodies from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Natural Killer Cell Therapies Market Size and Growth Rate of Cancer from 2014 to 2026

      • 1.4.2 Global Natural Killer Cell Therapies Market Size and Growth Rate of Gastrointestinal Diseases from 2014 to 2026

      • 1.4.3 Global Natural Killer Cell Therapies Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Natural Killer Cell Therapies Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Natural Killer Cell Therapies Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Natural Killer Cell Therapies by Major Types

      • 3.4.1 Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Therapies

      • 3.4.2 Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Directed Antibodies

    4 Segmentation of Natural Killer Cell Therapies Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Natural Killer Cell Therapies by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Natural Killer Cell Therapies in Cancer

      • 4.4.2 Market Size and Growth Rate of Natural Killer Cell Therapies in Gastrointestinal Diseases

      • 4.4.3 Market Size and Growth Rate of Natural Killer Cell Therapies in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Natural Killer Cell Therapies Production Analysis by Major Regions

    • 5.2 Global Natural Killer Cell Therapies Consumption Analysis by Major Regions

    • 5.3 Global Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis

    6 Product Commodity of Natural Killer Cell Therapies Market in Major Countries

    • 6.1 Top 5 Export Countries in Natural Killer Cell Therapies market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Natural Killer Cell Therapies market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Natural Killer Cell Therapies market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Natural Killer Cell Therapies market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Natural Killer Cell Therapies market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Natural Killer Cell Therapies market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Natural Killer Cell Therapies Landscape Analysis

    • 7.1 North America Natural Killer Cell Therapies Landscape Analysis by Major Types

    • 7.2 North America Natural Killer Cell Therapies Landscape Analysis by Major End-Users

    • 7.3 North America Natural Killer Cell Therapies Landscape Analysis by Major Countries

      • 7.3.1 United States Natural Killer Cell Therapies Market Volume and Growth Rate

      • 7.3.2 Canada Natural Killer Cell Therapies Market Volume and Growth Rate

      • 7.3.3 Mexico Natural Killer Cell Therapies Market Volume and Growth Rate

    8 Europe Natural Killer Cell Therapies Landscape Analysis

    • 8.1 Europe Natural Killer Cell Therapies Landscape Analysis by Major Types

    • 8.2 Europe Natural Killer Cell Therapies Landscape Analysis by Major End-Users

    • 8.3 Europe Natural Killer Cell Therapies Landscape Analysis by Major Countries

      • 8.3.1 Germany Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.2 UK Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.3 France Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.4 Italy Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.6 Spain Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.7 Belgium Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.8 Poland Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.9 Russia Natural Killer Cell Therapies Market Volume and Growth Rate

      • 8.3.10 Turkey Natural Killer Cell Therapies Market Volume and Growth Rate

    9 Asia Pacific Natural Killer Cell Therapies Landscape Analysis

    • 9.1 Asia Pacific Natural Killer Cell Therapies Landscape Analysis by Major Types

    • 9.2 Asia Pacific Natural Killer Cell Therapies Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Natural Killer Cell Therapies Landscape Analysis by Major Countries

      • 9.3.1 China Natural Killer Cell Therapies Market Volume and Growth Rate

      • 9.3.2 Japan Natural Killer Cell Therapies Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Natural Killer Cell Therapies Market Volume and Growth Rate

      • 9.3.4 India Natural Killer Cell Therapies Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Natural Killer Cell Therapies Market Volume and Growth Rate

      • 9.3.6 South Korea Natural Killer Cell Therapies Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Natural Killer Cell Therapies Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Natural Killer Cell Therapies Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Natural Killer Cell Therapies Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Natural Killer Cell Therapies Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Natural Killer Cell Therapies Market Volume and Growth Rate

      • 10.3.2 Brazil Natural Killer Cell Therapies Market Volume and Growth Rate

      • 10.3.3 Nigeria Natural Killer Cell Therapies Market Volume and Growth Rate

      • 10.3.4 South Africa Natural Killer Cell Therapies Market Volume and Growth Rate 

      • 10.3.5 Argentina Natural Killer Cell Therapies Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Innate

      • 11.1.1 Innate Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Nkarta Therapeutics

      • 11.2.1 Nkarta Therapeutics Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Fate Therapeutics

      • 11.3.1 Fate Therapeutics Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Fortress Biotech

      • 11.4.1 Fortress Biotech Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Chipscreen Biosciences

      • 11.5.1 Chipscreen Biosciences Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Glycostem

      • 11.6.1 Glycostem Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Nektar Therapeutics

      • 11.7.1 Nektar Therapeutics Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 NantWorks

      • 11.8.1 NantWorks Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Kiadis Pharma

      • 11.9.1 Kiadis Pharma Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Dragonfly Therapeutics

      • 11.10.1 Dragonfly Therapeutics Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Affimed

      • 11.11.1 Affimed Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 94 Figures and 164 Tables)

    • Figure Product Picture

    • Figure Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Therapies from 2014 to 2026

    • Figure Natural Killer Cell Therapies Market Size and Growth Rate of NK Cell Directed Antibodies from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of Cancer from 2014 to 2026

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of Gastrointestinal Diseases from 2014 to 2026

    • Figure Global Natural Killer Cell Therapies Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Natural Killer Cell Therapies Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Natural Killer Cell Therapies Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Natural Killer Cell Therapies

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Natural Killer Cell Therapies by Different Types from 2014 to 2026

    • Table Consumption Share of Natural Killer Cell Therapies by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of NK Cell Therapies

    • Figure Market Size and Growth Rate of NK Cell Directed Antibodies

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Natural Killer Cell Therapies by Different End-Users from 2014 to 2026

    • Table Consumption Share of Natural Killer Cell Therapies by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cancer

    • Figure Market Size and Growth Rate of Gastrointestinal Diseases

    • Figure Market Size and Growth Rate of Others

    • Table Global Natural Killer Cell Therapies Production by Major Regions

    • Table Global Natural Killer Cell Therapies Production Share by Major Regions

    • Figure Global Natural Killer Cell Therapies Production Share by Major Regions in 2014

    • Figure Global Natural Killer Cell Therapies Production Share by Major Regions in 2018

    • Figure Global Natural Killer Cell Therapies Production Share by Major Regions in 2026

    • Table Global Natural Killer Cell Therapies Consumption by Major Regions

    • Table Global Natural Killer Cell Therapies Consumption Share by Major Regions

    • Figure Global Natural Killer Cell Therapies Consumption Share by Major Regions in 2014

    • Figure Global Natural Killer Cell Therapies Consumption Share by Major Regions in 2018

    • Figure Global Natural Killer Cell Therapies Consumption Share by Major Regions in 2026

    • Table North America Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis

    • Table Europe Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Natural Killer Cell Therapies Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Natural Killer Cell Therapies market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Natural Killer Cell Therapies market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Natural Killer Cell Therapies market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Natural Killer Cell Therapies market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Natural Killer Cell Therapies Consumption by Types from 2014 to 2026

    • Table North America Natural Killer Cell Therapies Consumption Share by Types from 2014 to 2026

    • Figure North America Natural Killer Cell Therapies Consumption Share by Types in 2014

    • Figure North America Natural Killer Cell Therapies Consumption Share by Types in 2018

    • Figure North America Natural Killer Cell Therapies Consumption Share by Types in 2026

    • Table North America Natural Killer Cell Therapies Consumption by End-Users from 2014 to 2026

    • Table North America Natural Killer Cell Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure North America Natural Killer Cell Therapies Consumption Share by End-Users in 2014

    • Figure North America Natural Killer Cell Therapies Consumption Share by End-Users in 2018

    • Figure North America Natural Killer Cell Therapies Consumption Share by End-Users in 2026

    • Table North America Natural Killer Cell Therapies Consumption by Major Countries from 2014 to 2026

    • Table North America Natural Killer Cell Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Natural Killer Cell Therapies Consumption Share by Major Countries in 2014

    • Figure North America Natural Killer Cell Therapies Consumption Share by Major Countries in 2018

    • Figure North America Natural Killer Cell Therapies Consumption Share by Major Countries in 2026

    • Figure United States Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Natural Killer Cell Therapies Consumption by Types from 2014 to 2026

    • Table Europe Natural Killer Cell Therapies Consumption Share by Types from 2014 to 2026

    • Figure Europe Natural Killer Cell Therapies Consumption Share by Types in 2014

    • Figure Europe Natural Killer Cell Therapies Consumption Share by Types in 2018

    • Figure Europe Natural Killer Cell Therapies Consumption Share by Types in 2026

    • Table Europe Natural Killer Cell Therapies Consumption by End-Users from 2014 to 2026

    • Table Europe Natural Killer Cell Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Natural Killer Cell Therapies Consumption Share by End-Users in 2014

    • Figure Europe Natural Killer Cell Therapies Consumption Share by End-Users in 2018

    • Figure Europe Natural Killer Cell Therapies Consumption Share by End-Users in 2026

    • Table Europe Natural Killer Cell Therapies Consumption by Major Countries from 2014 to 2026

    • Table Europe Natural Killer Cell Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Natural Killer Cell Therapies Consumption Share by Major Countries in 2014

    • Figure Europe Natural Killer Cell Therapies Consumption Share by Major Countries in 2018

    • Figure Europe Natural Killer Cell Therapies Consumption Share by Major Countries in 2026

    • Figure Germany Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure France Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Natural Killer Cell Therapies Consumption by Types from 2014 to 2026

    • Table Asia Pacific Natural Killer Cell Therapies Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by Types in 2014

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by Types in 2018

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by Types in 2026

    • Table Asia Pacific Natural Killer Cell Therapies Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Natural Killer Cell Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by End-Users in 2014

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by End-Users in 2018

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by End-Users in 2026

    • Table Asia Pacific Natural Killer Cell Therapies Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Natural Killer Cell Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Natural Killer Cell Therapies Consumption Share by Major Countries in 2026

    • Figure China Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandNatural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure India Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Natural Killer Cell Therapies Consumption Share by Major Countries in 2026

    • Figure GCC Countries Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Natural Killer Cell Therapies Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Innate

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Innate

    • Figure Sales and Growth Rate Analysis of Innate

    • Figure Revenue and Market Share Analysis of Innate

    • Table Product and Service Introduction of Innate

    • Table Company Profile and Development Status of Nkarta Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nkarta Therapeutics

    • Figure Sales and Growth Rate Analysis of Nkarta Therapeutics

    • Figure Revenue and Market Share Analysis of Nkarta Therapeutics

    • Table Product and Service Introduction of Nkarta Therapeutics

    • Table Company Profile and Development Status of Fate Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fate Therapeutics

    • Figure Sales and Growth Rate Analysis of Fate Therapeutics

    • Figure Revenue and Market Share Analysis of Fate Therapeutics

    • Table Product and Service Introduction of Fate Therapeutics

    • Table Company Profile and Development Status of Fortress Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fortress Biotech

    • Figure Sales and Growth Rate Analysis of Fortress Biotech

    • Figure Revenue and Market Share Analysis of Fortress Biotech

    • Table Product and Service Introduction of Fortress Biotech

    • Table Company Profile and Development Status of Chipscreen Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chipscreen Biosciences

    • Figure Sales and Growth Rate Analysis of Chipscreen Biosciences

    • Figure Revenue and Market Share Analysis of Chipscreen Biosciences

    • Table Product and Service Introduction of Chipscreen Biosciences

    • Table Company Profile and Development Status of Glycostem

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glycostem

    • Figure Sales and Growth Rate Analysis of Glycostem

    • Figure Revenue and Market Share Analysis of Glycostem

    • Table Product and Service Introduction of Glycostem

    • Table Company Profile and Development Status of Nektar Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nektar Therapeutics

    • Figure Sales and Growth Rate Analysis of Nektar Therapeutics

    • Figure Revenue and Market Share Analysis of Nektar Therapeutics

    • Table Product and Service Introduction of Nektar Therapeutics

    • Table Company Profile and Development Status of NantWorks

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantWorks

    • Figure Sales and Growth Rate Analysis of NantWorks

    • Figure Revenue and Market Share Analysis of NantWorks

    • Table Product and Service Introduction of NantWorks

    • Table Company Profile and Development Status of Kiadis Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kiadis Pharma

    • Figure Sales and Growth Rate Analysis of Kiadis Pharma

    • Figure Revenue and Market Share Analysis of Kiadis Pharma

    • Table Product and Service Introduction of Kiadis Pharma

    • Table Company Profile and Development Status of Dragonfly Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dragonfly Therapeutics

    • Figure Sales and Growth Rate Analysis of Dragonfly Therapeutics

    • Figure Revenue and Market Share Analysis of Dragonfly Therapeutics

    • Table Product and Service Introduction of Dragonfly Therapeutics

    • Table Company Profile and Development Status of Affimed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Affimed

    • Figure Sales and Growth Rate Analysis of Affimed

    • Figure Revenue and Market Share Analysis of Affimed

    • Table Product and Service Introduction of Affimed


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.